FDA device listing
Fia Blood Glucose Monitoring System (G2)
FDA device listing 1509375778 · GL DIABETES CORPORATION
Key facts
| Proprietary names | Fia Blood Glucose Monitoring System (G2) |
|---|---|
| Owner/operator | GL DIABETES CORPORATION |
| Owner/operator number | 10035802 |
| Product codes | JJX, LFR, NBW |
| Device names | JJX - Single (Specified) Analyte Controls (Assayed And Unassayed), LFR - Glucose Dehydrogenase, Glucose, NBW - System, Test, Blood Glucose, Over The Counter |
| Device class | Class I, Class II |
| Classification regulations (21 CFR) | 862.1345, 862.1660 |
| Review panels | Clinical Chemistry |
| Registered establishments | GL DIABETES CORPORATION |
| Establishment registrations | 3009129531 |
| FEI numbers | 3009129531 |
| Establishment operations | Contract Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database